It also means Australian Parents are willing to pay more for an organic quality product. Competitors would need to push harder in volume to make up the same revenue, but not BAL.
Continued push to increase value sales will increase NPAT even further for 1HFY17. I don't see any price point increases in the future and so volume is key to further revenue/npat growth (which we have always known)
BAL will need to take this "#1" message to rest of the world to ramp up volume without the need to discount price like its competitors.
- Forums
- ASX - By Stock
- BAL
- Number #1 sales in Australia
Number #1 sales in Australia, page-15
-
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online